Jaypirca Disease Interactions
There are 2 disease interactions with Jaypirca (pirtobrutinib).
Pirtobrutinib (applies to Jaypirca) infections
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Severe infections (including bacterial, viral, and fungal) as well as opportunistic infections leading to fatal outcomes have been reported while on pirtobrutinib. Antimicrobial prophylaxis and vaccinations are recommended for patients with a high risk for infection. Assess and treat for infection when exhibited. Temporarily hold, decrease the dose, or discontinue therapy as indicated.
References
- (2023) "Product Information. Jaypirca (pirtobrutinib)." Lilly, Eli and Company
Pirtobrutinib (applies to Jaypirca) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Patients with severe renal impairment (eGFR 15 to 29 mL/min) can have increased exposure to pirtobrutinib and require a dosage reduction. No dosage modifications are required in patients with mild or moderate renal impairment.
References
- (2023) "Product Information. Jaypirca (pirtobrutinib)." Lilly, Eli and Company
Jaypirca drug interactions
There are 705 drug interactions with Jaypirca (pirtobrutinib).
Jaypirca alcohol/food interactions
There is 1 alcohol/food interaction with Jaypirca (pirtobrutinib).
More about Jaypirca (pirtobrutinib)
- Jaypirca consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.